Sage Journals: Discover world-class research

Abstract

Background

Morbidity and mortality related to acute poisoning is a major public health issue in both developing and developed countries. Community pharmacists have a crucial role in ensuring drug availability, increasing drug safety, counseling patients, overdose risk reduction and management, and provision of appropriate drug information. This study aimed to assess the availability of necessary antidotes in community pharmacies in Gondar and Bahir-Dar cities, Ethiopia, and the role of community pharmacists in the management of acute poisoning.

Methods

A cross-sectional survey was conducted in Gondar and Bahir-Dar cities. A self-administered, structured questionnaire was used for data collection and Statistical Package for Social Sciences (SPSS) version 24.0 was used for data analysis. Chi-square analysis was computed to identify the associated factors with a confidence interval of 95% and a P value less than .05 was used as a cut-point for statistical significance.

Results

Out of 101 community pharmacies invited to participate in the study, 80 of them completed the survey with a response rate of 79.2%. The overall mean antidote availability score was .59 (SD = .837), which falls within the definition of Poor availability. None of the pharmacies had kept all of the antidotes, and the maximum number of an antidote kept by a single pharmacy was 7 out of nineteen essential antidotes surveyed. The most commonly reported reason for the unavailability of essential antidotes was stock was not ordered (56.3%) followed by stock ordered but not delivered from suppliers (wholesalers) (20.0%). More than 3 fourth of the respondents (83.8%) had poor knowledge about the antidotes for the common poisonings.

Conclusion

There was a significantly very low availability of essential antidotes in the community pharmacies. Strategies should be implemented to improve pharmacist’s knowledge about antidotes, and management of poisoning emergencies through on-job training and provision of reference materials.

Keywords

poisoning antidote community pharmacy availability pharmacists

Introduction

Acute poisoning is a medical emergency in which the toxic effects occur almost immediately, usually within hours from the time of exposure.¹ Exposure to agrochemicals, medicines, and environmental agents may cause poisoning.² It is a common public health problem in low- and middle-income countries due to the absence of strong regulation and health care services.³ In many low-income countries food poisoning, an overdose of drugs, insecticidal, herbicides, animal biting, and plant poisonings are the common cause of poisoning in human beings among which organophosphate poisoning is the leading cause of death especially in rural areas.⁴

Currently, morbidity and mortality related to acute poisoning is a major public health issue in both developing and developed countries.¹ According to a WHO report, acute poisonings were estimated from 2 to 3 million cases annually; of which 1 million are severe poisonings resulting in 20, 000 deaths annually throughout the globe.^5,6 The report also showed the distribution of poisoning mortality by region in which it was 8% in Africa, 7% in America, 5% in Europe, 19% in the Eastern Mediterranean region, 7% in the Southeast Asian region, and 7% in the west pacific region.⁷ In Africa, organophosphate poisoning is a lead cause of poisoning. The report showed that in Zimbabwe around three-quarters of hospital admissions related to poisoning were due to self-poisoning using organophosphates and findings from Malawi revealed that 80% of suicide activities were using pesticide ingestion.⁸ However, evidence shows that the lack of reliable in-country data and under-reporting is very common in many countries and makes it difficult to know the true impact of acute poisoning in these countries.⁹ Taking snakebite envenoming alone, the under-reporting is believed to be over 70% in many developing countries, while conservative estimates show that, it kills 81,000–138,000 people every year, and leaves another 400,000 people with significant disabilities, such as amputated limbs and blindness.^9,10

Management of acute poisoning is a challenge for health professionals.⁴ It needs to properly define, identify, and quantify the causes of poisoning and the status of acutely poisoned patients.¹¹ Many countries do not have enough antidotes, screening tests, and proper treatment protocols.¹² In the management of poisoning, prevention from exposure to dangerous and potentially dangerous substances is very crucial. Antidotes are therapeutic substances that are important for the prevention or minimization of morbidity and mortality due to poisoning.¹³ Besides, it is also important that the right antidotes be administered at the right time and right dose. The management of poisoning requires adequately equipped medical support and multi-health professional experts including pharmacists.¹⁴

Pharmacists are one of the most trusted health professionals by consumers,¹⁵ and have an important role in the management of acute poisoning and strengthening the health care team.^16,17 For several years, pharmacies have also served as a sole source of drugs including antidotes for poisoning.¹⁶ In global health, community pharmacies have a crucial role in ensuring drug availability, increasing drug safety, counseling patients, overdose risk reduction and management, and provision of appropriate drug information.¹⁸ Besides, community pharmacists can also play an important role in the prevention of poisoning through the education and training of the public.¹⁹ It is therefore very important for a pharmacist to have adequate knowledge about poisoning and its management as well as know-how to respond to an emergency involving intentional or unintentional poisoning.^14,19 However, beyond these roles, pharmacists are underutilized throughout the world in the management of acute poisoning.¹⁸

Compared to many developed countries, very little is known about the prevalence, management practice, and outcome of poisoning in developing countries.²⁰ The availability of essential antidotes at health facilities including community pharmacies is also a great challenge for many developing countries. A study conducted in Pretoria, South Africa reported that there was great variability in the stocking of antidotes at the community pharmacies in which 40% of the surveyed pharmacies stocked no antidotes at all and none of the pharmacies kept all the 19 antidotes listed.²¹ Besides, frequent unavailability of antidotes at health care facilities, their expensive price, and often doubtful quality, forces many poisoning victims seek alternative and typically ineffective treatments from traditional healers.¹⁰

In Ethiopia, pharmaceutical products are available at health facility pharmacy stores and pharmacy settings in the community; pharmacies, drug stores, and/or rural drug vendors. Pharmacies, drug stores, and rural drug vendors are types of community pharmacy setups that differ by the number and type of pharmaceuticals they hold.²² In addition, pharmacies are run by pharmacy professionals that hold a pharmacy degree, and drug stores and rural drug vendors are managed by pharmacy diploma holders. In the country, there is unrestricted distribution and free access to insecticides, herbicides, and rodenticides which may contribute to the increased risk of the public to the hazardous effects of those substances.^23,24 One retrospective study conducted at the University of Gondar hospital, Ethiopia revealed that the prevalence of acute poisoning was .67% among patients admitted to the emergency ward of the hospital.²⁵

The Ethiopian Food and Drug Authority (the then Drug Administration and Control [DACA]) Proclamation stated that “no person shall manufacture, import and distribute poisons unless s/he first have obtained a special permit from the authority, and any person who manufactures, imports or distributes poisons, shall keep detailed records of such poisons per the directives that may be issued by the authority and reports to same.”²⁶ In Ethiopia, although there are initiatives to establish poisoning centers, they are not currently functional, and thus victims are directly reporting and being treated at the health facilities.^27,28

The following antidotes are listed in the National Essential Medicines List of Ethiopia (ENML); Acetylcysteine, Activated Charcoal, Calcium Gluconate Injection, Deferoxamine Mesylate, Digoxin Immune (Fab Ovine) Digoxin-specific, antibody fragments, Flumazenil, Lipid emulsion Injection, Phytomenadione (Vitamin K1), Sodium Nitrite, Physostigmine, Naloxone hydrochloride, Pralidoxime Chloride, Protamine sulfate, and Snake Venom Antiserum Polyvalent.²⁹ These antidotes together with additional antidotes not on the NEML (a total of 25 antidotes) are also included under the list of medicines for community pharmacies in Ethiopia.³⁰

To the authors' best knowledge, this is the first survey that summarized comprehensive data on the role of community pharmacists in the management of acute poisoning and the availability of antidotes among community pharmacies in Ethiopia. Therefore, this study aimed to assess the knowledge and practical aspects of community pharmacists in the management of acute poisoning, and the availability of essential antidotes in community pharmacies found in northern Ethiopia.

Study Methods

Study Design and Setting

A cross-sectional study was conducted from May 1^st to June 7, 2020, on community pharmacies in Bahir-Dar and Gondar cities, Amhara regional state, Ethiopia. Bahir-Dar is the capital city of the region and is situated 565 km from Addis Ababa, the capital city of the country, while Gondar is located 185 km away from Bahir-Dar. Based on a projection from the 2007 National Census, the population size of Bahir-Dar is estimated at around 249,851, and 227,100 for Gondar (34). At the time of the study, there were 14 pharmacies, 32 drug stores, and 8 rural drug vendors in Bahir-Dar, while there were 19 pharmacies and 33 drug stores in Gondar.

Sample Size Determination and Procedure

The source population was all licensed community pharmacies in Gondar and Bahir-Dar cities, Ethiopia. During the study period, there were 54 licensed pharmacies in Bahir-Dar and 52 pharmacies in Gondar, respectively. Of the total available pharmacies, 5 of them participated in the pretest which was used for validation of the data collection tools, and these were excluded from the final survey. Then, from the remaining pharmacies, only one pharmacist was taken as some pharmacies may have more than one pharmacist on the premises. A random sampling method was used to recruit the final interviewed pharmacists from each pharmacy.

Pharmacists that were not available at the time of data collection and those that declined to participate were left out of the study. In situations when there was more than one pharmacist in one pharmacy and if one of them had declined to participate or was not available during the data collection time, a chance was given for the next pharmacist available to participate in the study. Though it did not happen during the present study, if the next available pharmacist had also refused to participate, then the data collectors were told to move to the next available pharmacy leaving the unresponsive/unavailable one.

A total of 101 community pharmacists were invited to participate in the survey (Figure 1). Availability of antidotes and the different roles of pharmacists in poisoning management were considered as dependent variables and the independent variables include socio-demographic characteristics of the study participants (sex, age, educational level, residency, year of work experience…), previous education/training on poisoning management, etc. (Figure 2)

Figure 1.

Workflow.

Figure 2.

Conceptual framework. *Financial problems, transportation problem, complexity of the purchasing system.

Data Collection Tool and Technique

Data were collected by 6 well-trained data collectors; 3 data collectors from Bahir-Dar and 3 from Gondar, using a self-administered, structured questionnaire. The questionnaire was developed after a careful literature review of previously conducted similar studies.^21,31–33 The tool was pre-tested on 5 pharmacies and relevant modifications were performed before the commencement of the actual data collection. The final questionnaire constituted 17 items that were divided into 2 main sections. The first section was focusing on the socio-demographic characteristics related to information including age, gender, years of experience, residence, education level, and type of facility. The second section aimed to assess the availability of essential antidotes for common poisonings and the role of community pharmacists in the management of acute poisoning.

A pharmacy was classified as having a good availability of antidotes if it has stored ≥12 antidotes out of the 19 and classified as poor if have <12 antidotes. A pharmacist was classified as having good knowledge if correctly identify the antidotes for ≥5 out of the 8 toxicities and poor if responded for less than 5. Opioids, alcohol, benzodiazepines, digoxin, acetaminophen, iron, oral anti-coagulants, and heparin are the common causes of acute poisoning in Ethiopia.²⁸

Data Quality Assurance and Analysis

At the end of each day, the collected data were checked for completeness, accuracy, and consistency before feeding for analysis. The finally checked data were entered into and analyzed using Statistical Package for Social Sciences (SPSS) software for Windows version 24.0. Descriptive statistics like, frequency, percentage, mean, standard deviation, and median were used for data presentation. Chi-square analysis was computed to identify the associated factors with a confidence interval of 95% and a P value less than .05 was used as a cut-point for statistical significance.

Result

Demographic Information on the Study Participants

A total of 101 community pharmacies were approached (one pharmacist per pharmacy), and 80 of them had completed the survey with a response rate of 79.2%. About 44 pharmacists from Gondar and 36 pharmacists from Bahir-Dar city were participated with the majority of them being male respondents 45 (56.3%). The mean age of the respondents was 32.4 years (SD=9.45) of which half of the respondents (50.0%) being within the age range of 26–35 years. The larger share of the study participants 42 (52.5%) were degree holders followed by diploma holders 32 (40%). The mean year of work experience for the respondents was 8.08 years (SD=6.28) with more than one-fourth of the participants 23 (28.7%) having an experience of between 3 and 5 years (Table 1).

Table 1.

Socio-demographic characteristics of the study participants.

Characteristics	Frequency	Percentage (%)
Sex
Male	45	56.3
Female	35	43.8
Age
<25	16	20.0
26–35	40	50.0
36–45	17	21.3
>45	7	8.8
Educational level
Diploma	35	43.8
Degree	42	52.5
Masters	3	3.8
Years of experience
<2 years	13	16.3
3–5 years	23	28.7
6–10 years	22	27.5
>10 years	22	27.5
City of residence
Gondar	44	55.0
Bahir-Dar	36	45.0
Type of facility
Drug store	28	35.0
Pharmacy	52	65.0

Availability of Antidotes

The overall mean antidote availability score was .59 (SD=.837), which falls within the definition of “Poor availability.” None of the pharmacies has kept all of the antidotes and the maximum number of antidotes stored by a single pharmacy was 3. The majority of the pharmacies 58.8% do not have any of the antidotes. Only 12 (27.27%) pharmacies in Gondar and 21 (58.3%) from Bahir Dar had at least one antidote in their premises. From the total pharmacies surveyed, only 2.5% of them had activated charcoal and 3.8% had naloxone. The most available antidote in the pharmacies was Atropine (37.5%). There was also a significant difference concerning the availability of Folinic acid and Atropine in the 2 cities (P = .005 and P = .011), respectively (Table 2).

Table 2.

Availability of essential antidotes at community pharmacies.

Antidote’s Name	Availability of Antidotes						P value
	Total Respondents (n = 80)		Gondar (n = 44)		Bahir-Dar (n = 36)
	Yes n (%)	No n (%)	Yes n (%)	No n (%)	Yes n (%)	No n (%)
Activated charcoal	2 (2.5)	78 (97.5)	1 (2.3)	43 (97.7)	1 (2.8)	35 (97.2)	.701
Sodium polystyrene	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Sodium bicarbonate	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Folinic acid	14 (17.5)	66 (82.5)	3 (6.8)	41 (93.2)	11 (30.6)	25 (69.4)	.005
Acetyl cysteine	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Disulfiram	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Ipecacuanha	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Atropine	30 (37.5)	50 (62.5)	11 (25.0)	33 (75.0)	19 (52.8)	17 (47.2)	.011
Citric acid	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Sodium thiosulphate	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Sodium nitrite	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Naloxone	3 (3.8)	77 (96.3)	0 (.0)	44 (100.0)	3 (8.3)	33 (91.7)	.087
Dicobalt edetate	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Flumazenil	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Methylene blue	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Deferoxamine	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Dimercaprol	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Mesnaobidoxime	0 (.0)	80 (100.0)	0 (.0)	44 (100.0)	0 (.0)	36 (100.0)
Methionine	0 (.0)	80 (100.0)	0 (.0)	44 (100)	0 (.0)	36 (100.0)	.550

Among the available antidotes, folinic acid was present in 1 drug store from the total of 28 drug stores, and 13 pharmacies out of the total 52 surveyed have stocked the antidote. The difference between the type of facilities was also statistically significant (P=.016). Concerning atropine, 8 drug stores out of the 28 (40%) had the antidote in their premises while 42.3% of the pharmacies (22 out of 52) had it in stock. Naloxone was only present in the pharmacies, 3 out of 52, while on the other hand activated charcoal was present in a drug store only, 2 drug stores out of the total 28.

Reasons for Unavailability of Antidotes

The most commonly reported reason for the unavailability of essential antidotes was “stock was not ordered” 45 (56.3%) followed by “stock was ordered but not delivered from suppliers” 16 (20.0%). (Figure 3)

Figure 3.

Common reasons for the unavailability of essential antidotes at community pharmacies.

Knowledge of Community Pharmacists About the Common Antidotes

Table 3 described the knowledge of community pharmacists about the common poisoning agents’ antidote. The overall mean knowledge score of respondents was 1.33 (SD=2.198), which falls within the definition of “Poor Knowledge.” The maximum knowledge score was 7 and the minimum was zero. More than three-fourth of the respondents 67 (83.8%) had poor knowledge about the antidotes for the common poisonings. About 26 (32.5%) of the respondents correctly identified the antidote for opioids poisoning and 17 (21.3) of them knew the antidote for Benzodiazepine’s toxicity. However, only 2 (2.5%) of the respondents knew the antidote for alcohol toxicity (Table 4).

Table 3.

Factors associated with pharmacists’ ability to identify poisoning materials ingested by a patient.

Variable	Ability to Identify the Poisoning Material/Toxicity		P value
Variable	Yes (%)	No (%)	P value
The educational level of respondent
Diploma	6 (17.1)	29 (82.9)	.061
Degree	15 (35.7)	27 (64.3)
Masters	2 (66.6)	1 (33.4)
Years of work experience
<2 years	1 (7.7)	12 (92.3)	.312
3–5 years	7 (30.4)	16 (69.6)
6–10 years	8 (36.3)	14 (63.7)
>10 years	7 (31.8)	15 (68.2)
Previous education/training on toxicology/poisoning management
Yes	21 (40.4)	31 (59.6)	.002
No	2 (7.1)	26 (92.9)	.002
Residency (city)
Bahir-Dar	11 (30.6)	25 (69.4)	.747
Gondar	12 (27.3)	32 (72.7)	.747

Table 4.

Pharmacists’ response to the antidotes for common poisonings/toxicities.

Type of Poisoning Agents	Pharmacist Response
Type of Poisoning Agents	Correctly Identified n (%)	Not Correctly Identified n (%)
Opioids	26 (32.5)	53 (66.3)
Alcohol	2 (2.5)	78 (97.5)
Benzodiazepines	17 (21.3)	62 (77.5)
Digoxin	6 (7.5)	73 (91.3)
Acetaminophen	16 (20.0)	63 (78.8)
Iron toxicity	14 (17.5)	66 (82.5)
Oral anti-coagulant	11 (13.8)	68 (85.0)
Heparin	14 (17.5)	65 (81.3)

Poisoning Management Practice of Community Pharmacists

Near to two-thirds 52 (65.0%) of the pharmacists reported that they have taken an education/training about types of poisons and their management though only 28.7% of them reported that they were able to identify the specific type of poisoning material ingested if a poisoned person was presented to their pharmacy unconscious using the patients’ symptoms and/or additional physical diagnosis. Among the total community pharmacists, only 8.8% had the experience of a patient with an acute poisoning case (Table 5). Of them, the majority (42.8%) did not remember the type of poisoning while 28.6% reported it was organophosphate poisoning. (Figure 4)

Table 5.

Roles of community pharmacists in the prevention/management of acute poisoning.

Questions	Frequency (N = 80)
Questions	Yes n (%)	No n (%)
Have you taken a course during your studies about types of poisons and their management?	52 (65.0)	28 (35.0)
Do you always counsel your patients with the correct dosage regimen of the medications you dispense?	80 (100.0)	0 (.0)
Do you always counsel your patients to put medications out of reach of children?	47 (58.8)	33 (41.3)
If a poisoned person presented to your pharmacy unconscious, can you tell the type of material he/she may have ingested via examination of the signs and symptoms and/or any other physical diagnosis?	23 (28.7)	57 (71.3)
Did you have an experience/history of a poisoned patient presented to your pharmacy?	7 (8.8)	73 (91.3)

Figure 4.

Common poisoning materials for the poisoning cases experienced at community pharmacies in Gondar and Bahir-Dar (N = 7).

When asked about what was the first thing they will do if a poisoned person suddenly presented to their facility, 29 (36.3%) of them reported that they will refer to a physician while 22 (27.5%) reported that they will first ask what happened. (Figure 5)

Figure 5.

First measure taken by community pharmacists if a poisoned person presented to them (N = 80).

Chi-square analysis was also conducted to identify factors associated with the pharmacist’s ability to identify the poisoning agent a patient may have ingested when presented unconscious to his/her facility. The results showed that previous education/training on toxicology/poisoning management was significantly associated with pharmacists’ ability to identify the causative agents (P = .002) (Table 3).

Discussion

The present study assessed the pattern of essential antidotes availability at 2 cities in North Ethiopia and examined the role played by community pharmacists in the management of acute poisoning.

The study revealed that from the total community pharmacies surveyed, the majority of them (58.8%) do not have any of the essential antidotes and the overall mean antidote availability score was also significantly very low. This finding was very lower when compared with a similar study conducted in Pretoria, South Africa in which 60% of the community pharmacies surveyed had at least one antidote and the maximum number of an antidote stored by a single pharmacy being 11/19 compared with 3/19 in the current study.²¹ This is very concerning because antidotes are the mainstay of treatment for poisoned patients and their availability is a crucial factor for the overall prognosis and outcome of the patient. Even though the occurrence of acute poisoning is a rare condition, if it is not properly treated for the first time, it can result in serious consequences for the patient’s future health (including death) in which the timely administration of an antidote is a determinant.¹⁴

In the current study, the overall percentage availability of activated charcoal is significantly very low, 2.5%. This is very concerning since organophosphate (pesticides) poisoning and toxicity from bleaching agents are the common types of poisonings in Ethiopia for which activated charcoal is an important component of the management protocol.^28,32 Organophosphates and bleaching agents were the leading causes of poisoning in studies conducted in Addis Ababa,^31,34 and Gondar.²⁵ This showed that activated charcoal should always be available in every pharmacy premises and stocked in enough amounts.

The most commonly reported reasons for the unavailability of essential antidotes were not ordering the stock, the stock is ordered but not delivered from suppliers, the proximity of the pharmacies to hospitals, and the previous expiry of antidotes without being used, respectively. These findings were similar to a study conducted in Pretoria, South Africa.²¹ Even though some of the reasons may be logical, such as because of fear of money loss due to expiry as many of them may not be utilized, it is not acceptable not to order or keep antidotes for only fear of financial loss as this will leave the community in great danger. Any delay in the administration of an antidote for any reason could negatively affect the overall prognosis of the patient and could also increase his/her chance of death from the poisoning. Similarly, proximity to a hospital is not a valuable reason for not keeping antidotes because hospitals may also not have a regular stock of antidotes or may run out of stock. One probable reason that may be associated with the health care system could be “stock being ordered but not delivered from suppliers,” as this may rather denote a problem in the pharmaceutical supply chain system. In the Ethiopian health care system, public health facilities (public hospitals, health centers and health posts) mainly obtain their pharmaceuticals including antidotes from the government, the Ethiopian Pharmaceutical Supply Agency (EPSA), unless the agency is stocked-out itself and in which case they can procure from private agencies. However, private health institutions including community pharmacies can purchase pharmaceuticals from EPSA and/or private companies without any restriction.

In the present study, more than 3 fourth of the respondents had poor knowledge about the antidotes for the common poisonings, and more than 3 fourth of them were unable to identify the specific type of poisoning material using the patients’ symptoms and/or any additional physical diagnosis, if he/she presented to them unconsciously. This is very worrying because pharmacists are expected to master such kinds of knowledge due to their expertise (as they took pharmacology and toxicology courses more than the other health professionals) and this will render them from making a significant contribution to the management of poisoned patients.¹⁹

A pharmacist is expected to contribute to the management of poisoning/toxicity in various ways. As a result of his/her detailed knowledge of over-the-counter and prescription drugs, and other potentially dangerous materials, a pharmacist can serve to make judgments on the type of material ingested and the toxic liability of that specific material.¹⁹ She/he can do this not only through the gross examination of the product, but the specific analysis of the ingested material that s/he acquired through his/her training in analytical and medicinal chemistry. With additional information from the patients’ caregivers or other sources, the pharmacist should also be more familiar with other medications that the poisoned person may also be taking and he/she can contribute to the therapeutic management by selecting the appropriate drug therapy for that particular patient.¹⁹

Evidence from a previous study conducted in Ethiopia showed that the education level of victims of acute poisoning was reported to be lower.³⁵ This brings a huge responsibility for pharmacists to master a great deal of knowledge in the overall aspects of poisoning prevention and management. They should provide proper counseling and guidance to such victims whenever presented to their premises to prevent future similar incidences. Such types of counseling services should also include psychological guidance and support as previous studies reveal that intentional poisonings were very common in Ethiopia.^25,34–37 As such, pharmacists need to equip themselves with such kinds of knowledge and skill to provide good pharmaceutical care, and effectively execute their professional responsibility.

In general, the present study revealed that the availability of antidotes for managing poisoning emergencies at community pharmacies is incomplete and needs to be improved. Recent evidence shows that antidote deficiency is a worldwide problem but the degree of the problem and the main reasons are different across countries.^38–41 Stringent policies that ensure the availability of essential antidotes at health care facilities and monitoring pharmacy professionals’ ability to manage emergency poisonings are mandatory. The ministry of health and other local governments may need to impose stringent regulations regarding the availability of essential antidotes at these facilities and punish those that violated the regulations. For example, in the United States, the state of California has sanctioned a hospital for violating a regulation that require the availability of prescribed medications 24 hours a day.⁴² In addition, it is recommended that pharmacies have sufficient items of antidotes to improve the overall management practice of acute poisoning and pharmacy professionals should take the responsibility in preparing a list of antidotes that should be available at their premises at all times. This could also include the adaptation of clear procurement procedures for obtaining other antidotes in an emergency, as it is in New Zealand.³⁸ Organizing an expert panel representing diverse disciplines such as; clinical pharmacology, medical toxicology, critical care medicine, hematology/oncology, hospital pharmacy, emergency medicine, emergency medical services, pediatric emergency medicine, pediatric critical care medicine, poison centers, hospital administration, and public health could be an effective strategy to create recommendations for antidote stocking.⁴³

Strategies should also be implemented to improve the overall knowledge of community pharmacy professionals on how to identify and treat emergency poisonings. Evidence shows that, overall antidote awareness creation programs and continuous educational programs of health care professionals together with record keeping of poisonous cases are very effective strategies.⁴⁰ Besides, in addition to providing educational programs, higher education institutes such as Universities could also engage in establishing poisoning centers and collaborate with health care institutions (hospitals).³⁹

Limitation of the Study

As the current study is a cross-sectional study, it cannot reveal a cause-and-effect relationship. The second limitation could be, as most of the answers were dependent on the pharmacist’s response to the various questions, there may be respondent bias in case of some sensitive questions. The study was conducted in 2 cities, Bahir-Dar and Gondar, and thus even if most cities and health programs in the country may share similar characteristics, generalization of the results to other geographic areas with different properties could be difficult.

Conclusion

There was a significantly very low availability of essential antidotes in the community pharmacies. The pharmacist’s knowledge about poisoning materials and their antidotes was also unsatisfactory denoting a need for further training in the subject area. Gaps in the supply chain system were also identified that could determine the timely availability of essential antidotes.

Recommendations

Community pharmacies should keep essential antidotes in their premises at all times with a particular focus on antidotes used for the most common acute poisonings in the areas. Strategies should be implemented to improve pharmacist’s knowledge about antidotes, and management of poisoning emergencies through on-job training and provision of reference materials. Improvements are also needed in the pharmaceutical supply chain system as the supply lead-time to avail essential antidotes on time is a very determinant factor for the effective management of acute poisonings.

Footnotes

Acknowledgments

The authors would like to thank all the study participants for their participation and collaboration in the study.

Author’s contributions

All authors contributed equally to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Competing interests

The authors declare that they have no competing interests.

Funding

The author’s received no specific funding for this work.

Ethical Consideration

The ethical committee of the school of pharmacy, the University of Gondar, had approved this study with an approval number of SoP-784/2020. The study was performed following the Declaration of Helsinki as revised in 2013 and the study participants were well informed about the purpose of the study as well as participation was voluntary. Informed written consent was obtained from each of the participants before data collection, and the data was collected anonymously with no personally traceable information on the questionnaire. The confidentiality of the data was also maintained throughout the study.

Consent for publication

All the authors have given their final approval of the manuscript and agreed for publication.

Availability of data and materials

The data sets generated and/or analyzed during the current study are not available in public due to the requirement of confidentiality upon which consent was secured from the study participants but is available from the corresponding author on reasonable request.

ORCID iD

Zemene Demelash Kifle

References

Malangu

Ogunbanjo

G. A.

. A profile of acute poisoning at selected hospitals in South Africa. South Afr J Epidemiol Infect. 2009;24(2):14-16.

Chowdhary

Banerjee

Brahma

Biswas

. Pesticide poisoning in nonfatal, deliberate self-harm: A public health issue. Indian J Psychiatr. 2007;49(2):117.

Kaale

Mori

Risha

Hasham

Mwambete

. A retrospective study of poisoning at Muhimbili National Hospital in Dar-Es Salaam, Tanzania. Publ Health Front. 2013;2(1):21-26.

Sharma

Pandit

. Importance of poison information center and role of a pharmacist in management of poisoning. Int J Pharm Teach Pract. 2014;5(1):905-909.

Moazzam

Al Saigul

A. M.

Naguib

Al Alfi

M. A.

. Pattern of acute poisoning in Al-Qassim region: A surveillance report from Saudi Arabia, 1999-2003. East Mediterr Health J. 2009;15(4):1005-1010.

Banerjee

Tripathi

Roy

. Clinico-epidemiological characteristics of patients presenting with organophosphorus poisoning. N Am J Med Sci. 2012;4(3):147.

Thanacoody

Caravati

E. M.

Troutman

, et al. Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol. 2015;53(1):5-12.

World Health Organization . Safer Access to Pesticides: Community Interventions. World Health Organization; 2006.

World Health Organization . Snakebite Envenoming: A Strategy for Prevention and Control. World Health Organization; 2019.

10.

Williams

D. J.

Faiz

M. A.

Abela-Ridder

, et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl Trop Dis. 2019;13(2):e0007059.

11.

Malangu

. Acute poisoning at two hospitals in Kampala-Uganda. J Forensic Leg Med. 2008;15(8):489-492.

12.

Betten

D. P.

Vohra

R. B.

Cook

M. D.

Matteucci

M. J.

Clark

R. F.

. Antidote use in the critically ill poisoned patient. J Intensive Care Med. 2006;21(5):255-277.

13.

Woolf

A. D.

Chrisanthus

. On-site availability of selected antidotes: results of a survey of Massachusetts hospitals. Am J Emerg Med. 1997;15(1):62-66.

14.

Luisetto

. Journal of Applied Pharmacy. 2016.

15.

Poll

. Honesty/ethics in Professions. Gallup. Retrieved from; 2015.

16.

World Health Organization WHO Patient Safety . WHO Guidelines on Hand Hygiene in Health Care. World Health Organization; 2009:270.

17.

Anderson

. Making Medicines: A Brief History of Pharmacy and Pharmaceuticals. Pharmaceutical Press; 2005.

18.

Nacopoulos

A. G.

Lewtas

A. J.

Ousterhout

M. M.

. Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective. J Am Pharmaceut Assoc. 2010;50(2):148-157.

19.

Kinnard

W. J.

. The Role of the Pharmacist in the Control of Acute Poisoning. Taylor & Francis; 1971.

20.

Bundotich

J. K.

Gichuhi

. Acute poisoning in the rift valley provincial general hospital, Nakuru, Kenya: January to June 2012. S Afr Fam Pract. 2015;57(3):1-5.

21.

Malangu

. Availability of selected antidotes in community pharmacies in Pretoria. South Afr J Epidemiol Infect. 2006;21(4):170-172.

22.

Yazie

T. D

Tebeje

M. G.

Chufa

K. A.

. Healthcare waste management current status and potential challenges in Ethiopia: a systematic review. BMC Res Note. 2019;12(1):285-7.

23.

Mekuria

Y. M.

Tesfamariam

Teferra

. Insecticides sold in the streets of addis ababa for domestic use and the possible public health hazard associated with the practice. Ethiop J Health Dev. 1984;1(1).

24.

Daly

F. F. S.

Little

Murray

. A risk assessment based approach to the management of acute poisoning. Emerg Med J. 2006;23(5):396-399.

25.

Adinew

G. M.

Asrie

A. B.

Birru

E. M.

. Pattern of acute organophosphorus poisoning at university of gondar teaching hospital, Northwest Ethiopia. BMC Res Note. 2017;10(1):149-6.

26.

Suleman

Woliyi

Woldemichael

, et al. Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation. Ethiop J Health Sci. 2016;26(3):259-276.

27.

World Health Organization . Improving the Availability of Poisons Centre Services in Eastern Africa: Highlights from a Feasibility Study for a Subregional Poison Centre in the Eastern Africa Subregion, Including a Toolkit on Setting up a Poisons Information Service. World Health Organization; 2015.

28.

Chelkeba

Mulatu

Feyissa

Bekele

Tesfaye

B. T.

. Patterns and epidemiology of acute poisoning in Ethiopia: Systematic review of observational studies. Arch Public Health. 2018;76(1):34.

29.

Ministry of Health/Ethiopian Food and Drug Authority . Ethiopian Essential Medicines List. 6th ed. Addis Ababa: Ministry of Health/Ethiopian Food and Drug Authority: 2020. http://www.fmhaca.gov.et/publication/ethiopian-essential-medicines-list-sixth-edition-2020-2/. Accessed September, 2020.

30.

Ethiopian Food, Medicine and Healthcare Administration and Control Authority . Continuing Professional Development (CPD) Guideline for Health Professionals in Ethiopia Addis Ababa: FMoH; 2013.

31.

Melese

. Assessment of Prevalence, Management and Outcome of Acute Poisoning at St. Paul‘s Hospital Millennium Medical College and Addis Ababa Burn, Emergency and Trauma Hospital. Ethiopia: Addis Ababa University; 2018.

32.

Adinew

G. M.

Woredekal

A. T.

DeVos

E. L.

Birru

E. M.

Abdulwahib

M. B.

. Poisoning cases and their management in emergency centres of government hospitals in northwest Ethiopia. Afr J Emerg Med. 2017;7(2):74-78.

33.

Abd-Elhaleem

Z. A. E.

Al Muqhem

. Pattern of acute poisoning in Al Majmaah region, Saudi Arabia. Am J Clin Exp Med. 2014;4(2):79-85.

34.

Desalew

Aklilu

Amanuel

Addisu

Ethiopia

. Pattern of acute adult poisoning at Tikur Anbessa specialized teaching hospital, a retrospective study, Ethiopia. Hum Exp Toxicol. 2011;30(7):523-527.

35.

Teklemariam

Tesema

Jemal

. Pattern of acute poisoning in Jimma University specialized hospital, south West Ethiopia. World J Emerg Med. 2016;7(4):290.

36.

Wakushie

Daba

F. B.

. Pattern of acute poisoning and management outcome among patients presented to Adama referral hospital, Ethiopia. Medical Data. 2016;8(3):185-189.

37.

Chala

T. S.

Gebramariam

Hussen

. Two-Year Epidemiologic Pattern of Acute Pharmaceutical and Chemical Poisoning Cases Admitted to Adama Hospital Medical College, Adama, Ethiopia. Asia Pac J Med Toxicol. 2015;4(3): 106-111.

38.

Abbott

Creighton

Hannam

Vincent

Coulter

. Access in New Zealand to antidotes for accidental and intentional drug poisonings. Journal of primary health care. 2012;4(2):100-105.

39.

Al-Sohaim

S. I.

Awang

Zyoud

S. e. H.

Rashid

S. M.

Hashim

. Evaluate the impact of hospital types on the availability of antidotes for the management of acute toxic exposures and poisonings in Malaysia. Hum Exp Toxicol. 2012;31(3):274-281.

40.

Arslan

Khiljee

Bakhsh

Ashraf

Maqsood

. Availability of antidotes and key emergency drugs in tertiary care hospitals of Punjab and assessment of the knowledge of health care professionals in the management of poisoning cases. Pak J Pharm Sci. 2016;29(2):603-7.

41.

Sohn

C. H.

Ryoo

S. M.

Lim

K. S.

Kim

Lim

B. J.

. Kind and estimated stocking amount of antidotes for initial treatment for acute poisoning at emergency medical centers in Korea. J Kor Med Sci. 2014;29(11):1562-1571.

42.

Schwarzenegger

Belshé

. SB 1159 Report: An Evaluation of Over-the-Counter Sale of Sterile Syringes in California. California Health and Human Services Agency; 2009.

43.

Dart

R. C.

Borron

S. W.

Caravati

E. M.

, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2009;54(3):386-394.

Availability of Essential Antidotes and the Role of Community Pharmacists in the Management of Acute Poisoning: A Cross-Sectional Study in Ethiopia

Abstract

Background

Methods

Results

Conclusion

Keywords

Introduction

Study Methods

Study Design and Setting

Sample Size Determination and Procedure

Data Collection Tool and Technique

Data Quality Assurance and Analysis

Result

Demographic Information on the Study Participants

Availability of Antidotes

Reasons for Unavailability of Antidotes

Knowledge of Community Pharmacists About the Common Antidotes

Poisoning Management Practice of Community Pharmacists

Discussion

Limitation of the Study

Conclusion

Recommendations

Footnotes

Acknowledgments

Author’s contributions

Competing interests

Funding

Ethical Consideration

Consent for publication

Availability of data and materials

ORCID iD

References